These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34207346)

  • 1. Total Keratin-18 (M65) as a Potential, Early, Non-Invasive Biomarker of Hepatocyte Injury in Alcohol Intoxicated Adolescents-A Preliminary Study.
    Zdanowicz K; Olanski W; Kowalczuk-Kryston M; Bobrus-Chociej A; Werpachowska I; Lebensztejn DM
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure.
    Zheng SJ; Liu S; Liu M; McCrae MA; Li JF; Han YP; Xu CH; Ren F; Chen Y; Duan ZP
    World J Gastroenterol; 2014 Mar; 20(9):2403-11. PubMed ID: 24605039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspase-cleaved keratin-18 fragments increase during alcohol withdrawal and predict liver-related death in patients with alcoholic liver disease.
    Mueller S; Nahon P; Rausch V; Peccerella T; Silva I; Yagmur E; Straub BK; Lackner C; Seitz HK; Rufat P; Sutton A; Bantel H; Longerich T
    Hepatology; 2017 Jul; 66(1):96-107. PubMed ID: 28170108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts.
    Thulin P; Nordahl G; Gry M; Yimer G; Aklillu E; Makonnen E; Aderaye G; Lindquist L; Mattsson CM; Ekblom B; Antoine DJ; Park BK; Linder S; Harrill AH; Watkins PB; Glinghammar B; Schuppe-Koistinen I
    Liver Int; 2014 Mar; 34(3):367-78. PubMed ID: 24118944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propofol or sevoflurane anaesthesia does not affect hepatic integrity as assessed by the M30 & M65 cell death markers & liver enzymes.
    Chondrogiannis K; Hadziyannis E; Fassoulaki A
    Indian J Med Res; 2014 Nov; 140(5):630-6. PubMed ID: 25579144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Death and Prognosis of Mortality in Alcoholic Hepatitis Patients Using Plasma Keratin-18.
    Woolbright BL; Bridges BW; Dunn W; Olson JC; Weinman SA; Jaeschke H
    Gene Expr; 2017 Nov; 17(4):301-312. PubMed ID: 28770701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum levels of cell death circulating biomarkers, M30 and M65, in patients with β-thalassemia major.
    Esmaeil N; Moayedi B; Gharagozloo M; Maracy MR
    Hemoglobin; 2013; 37(4):404-10. PubMed ID: 23600495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cytokeratin 18 as a biomarker for gastric cancer.
    Oyama K; Fushida S; Kinoshita J; Okamoto K; Makino I; Nakamura K; Hayashi H; Inokuchi M; Nakagawara H; Tajima H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fujimura T; Ohta T
    Clin Exp Med; 2013 Nov; 13(4):289-95. PubMed ID: 22825587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of serum M30 and M65 in patients with nasopharyngeal carcinoma.
    Sen F; Yildiz I; Odabas H; Tambas M; Kilic L; Karadeniz A; Altun M; Ekenel M; Serilmez M; Duranyildiz D; Bavbek S; Basaran M
    Tumour Biol; 2015 Feb; 36(2):1039-44. PubMed ID: 25326440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic sonic hedgehog protein expression measured by computer assisted morphometry significantly correlates with features of non-alcoholic steatohepatitis.
    Estep M; Mehta R; Bratthauer G; Alaparthi L; Monge F; Ali S; Abdelatif D; Younoszai Z; Stepanova M; Goodman ZD; Younossi ZM
    BMC Gastroenterol; 2019 Feb; 19(1):27. PubMed ID: 30744560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer.
    de Haas EC; di Pietro A; Simpson KL; Meijer C; Suurmeijer AJ; Lancashire LJ; Cummings J; de Jong S; de Vries EG; Dive C; Gietema JA
    Neoplasia; 2008 Oct; 10(10):1041-8. PubMed ID: 18813353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers.
    Shen J; Chan HL; Wong GL; Chan AW; Choi PC; Chan HY; Chim AM; Yeung DK; Yu J; Chu WC; Wong VW
    Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1057-66. PubMed ID: 23066946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum keratin-18 detects hepatic inflammation and predicts progression in compensated alcohol-associated liver disease.
    Thorhauge KH; Thiele M; Detlefsen S; Rasmussen DN; Johansen S; Madsen BS; Antonsen S; Rasmussen LM; Lindvig KP; Krag A
    Hepatol Commun; 2022 Dec; 6(12):3421-3432. PubMed ID: 36264145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum hepatocyte apoptosis biomarker predicts the presence of significant histological lesion in chronic hepatitis B virus infection.
    Cao ZJ; Li J; Wang Y; Bao R; Liu YH; Xiang XG; Lin LY; Ye FX; Lu J; Xie Q; Bao SS; Wang H
    Dig Liver Dis; 2016 Dec; 48(12):1463-1470. PubMed ID: 27575659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.
    Ozturk B; Coskun U; Sancak B; Yaman E; Buyukberber S; Benekli M
    Int Immunopharmacol; 2009 May; 9(5):645-8. PubMed ID: 19249390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?
    Bilici A; Ustaalioglu BB; Ercan S; Orcun A; Seker M; Salepci T; Gumus M
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):309-16. PubMed ID: 20967544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis.
    Bissonnette J; Altamirano J; Devue C; Roux O; Payancé A; Lebrec D; Bedossa P; Valla D; Durand F; Ait-Oufella H; Sancho-Bru P; Caballeria J; Ginès P; Boulanger CM; Bataller R; Rautou PE
    Hepatology; 2017 Aug; 66(2):555-563. PubMed ID: 28120471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating apoptotic and necrotic cell death markers in patients with acute liver injury.
    Craig DG; Lee P; Pryde EA; Masterton GS; Hayes PC; Simpson KJ
    Liver Int; 2011 Sep; 31(8):1127-36. PubMed ID: 21745283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer.
    Yildiz I; Tas F; Kilic L; Sen F; Saip P; Eralp Y; Keskin S; Karabulut S; Ciftci R; Serilmez M; Yasasever V; Aydiner A
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):437-44. PubMed ID: 23801282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.
    Cummings J; Ranson M; Lacasse E; Ganganagari JR; St-Jean M; Jayson G; Durkin J; Dive C
    Br J Cancer; 2006 Jul; 95(1):42-8. PubMed ID: 16804528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.